At a time when more people are looking to save money on prescription drugs, their exposure to counterfeit drugs is rising, says Pfizer's head of counterfeit intelligence.

Phony medicines are increasingly making it across U.S. borders, often via Internet sales, and creating a threat to consumer safety, says John Theriault, a former FBI agent who now serves as the vice president of global security for Pfizer Inc. Occasionally, the phony medicines even make it into the legitimate sales stream.

25 July 2006

Read the full story at